cobimetinib
Facts
15 properties- Instance of
- type of chemical entity
- Subclass of
- [3,4-Difluoro-2-(2-fluoro-4-iodoanilino)phenyl][3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl]methanone
- Has use
- medication
- Active ingredient in
- Cotellic
- Canonical SMILES
- C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O
- Chemical formula
- C₂₁H₂₁F₃IN₃O₂
- Isomeric SMILES
- C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O
- LiverTox likelihood score
- LiverTox toxicity likelihood category D
- Mass
- 531.063 Da
- Medical condition treated
- metastatic melanoma, melanoma
- Physically interacts with
- Mitogen-activated protein kinase kinase 1, Mitogen-activated protein kinase kinase 2, mitogen-activated protein kinase kinase 7
- Pregnancy category
- Australian pregnancy category D
- Stereoisomer of
- [3,4-Difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2R)-piperidin-2-yl]azetidin-1-yl}methanone
- Subject has role
- protein kinase inhibitors
- World Health Organisation international non-proprietary name
- cobimetinib
- ATC code
- L01EE02
- CAS Registry Number
- 934660-93-2
- ChEBI ID
- 90851
- ChEMBL ID
- CHEMBL2146883
- ChemSpider ID
- 17349374
- DSSTOX compound identifier
- DTXCID80161926
- DSSTox substance ID
- DTXSID60239435
- DrugBank ID
- DB05239
- DrugCentral ID
- 5046
- Freebase ID
- /m/0wqyv0d
- Guide to Pharmacology Ligand ID
- 7626
Show all 29 identifiers +17
- InChIKey
- BSMCAPRUBJMWDF-KRWDZBQOSA-N
- KEGG ID
- D10405
- LiverTox ID
- Cobimetinib
- MedlinePlus drug identifier
- a615057
- Microsoft Academic ID (discontinued)
- 2779385430
- NDF-RT ID
- N0000192139
- PDB ligand ID
- EUI
- Probes And Drugs ID
- PD009336
- PubChem CID
- 16222096
- Reaxys registry number
- 12883594
- RxNorm CUI
- 1722365
- SureChEMBL ID
- 189565
- UMLS CUI
- C4049146
- UNII
- ER29L26N1X
- UniChem compound ID
- 27308527
- WikiProjectMed ID
- Cobimetinib
← Drug or therapy used for treatment 2
Has use 1
Medical condition treated 1
Subject has role 1
0 sources
Summary
cobimetinib is a type of chemical entity[1]. cobimetinib is a type of [3,4-Difluoro-2-(2-fluoro-4-iodoanilino)phenyl][3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl]methanone[2].
Key Facts
- Physically interacts with: Mitogen-activated protein kinase kinase 1[3], Mitogen-activated protein kinase kinase 2[4], mitogen-activated protein kinase kinase 7[5]
- Canonical SMILES: C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O[6]
- Chemical formula: C₂₁H₂₁F₃IN₃O₂[7]
- Has use: medication[8]
- Isomeric SMILES: C1CCNC@@HC2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)OC@@HC2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O">[9]
- Mass: 531.063 dalton[10]
- Medical condition treated: metastatic melanoma[11], melanoma[12]
- World Health Organisation international non-proprietary name: cobimetinib[13]
- Subject has role: protein kinase inhibitors[14]
- Stereoisomer of: [3,4-Difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2R)-piperidin-2-yl]azetidin-1-yl}methanone[15]
- Pregnancy category: Australian pregnancy category D[16]
- Active ingredient in: Cotellic[17]
- LiverTox likelihood score: LiverTox toxicity likelihood category D[18]